Abstract
Approximately 1% to 2% of persons in the general population are homozygous for a lipoprotein receptor-binding defective form of apoE (apoE2/2). However, only a small percentage (2% to 5%) of all apoE2/2 homozygotes develop type III hyperlipoproteinemia. Interaction with other genetic and environmental factors are required for the expression of this lipid abnormality. We sought to investigate tile possible role of LPL gene mutations in the development of hyperlipoproteinemia in apoE2/2 homozygotes and in apoE2 heterozygotes. As a first step, we performed DNA sequence analysis of all 10 LPL coding exons in 2 patients with the apoE2/2 genotype who had type III hyperlipoproteinemia and identified a single missense mutation (Asn 291→Ser) in exon 6 of the LPL gene. The mutation was then found in 5 of 18 patients with type III hyperlipoproteinemia who had the apoE2/2 genotype (allele frequency 13.9%; P ≤ 7.4 x 10-5) and h of 22 hyperlipidemic E2 heterozygous patients with the apoE3/2 and E4/2 genotype (allele frequency 13.6%; P = 2.2 x 10-5). In contrast, this mutation was found in only 3 of 230 normolipidemic controls (allele frequency=0.7%). In vitro mutagenesis studies revealed that the Asn 291→Ser mutant LPL had approximately 60% of LPL catalytic activity and approximately 70% of specific activity compared with wild-type LPL. The heparin-binding affinity of the mutant LPL was not impaired. Our data suggest that the Asn 291→Ser substitution is likely to he a significant predisposing factor contributing to the expression of different forms of hyperlipidemia when associated with other genetic factors such as the presence of apoE2.
Original language | English (US) |
---|---|
Pages (from-to) | 1695-1703 |
Number of pages | 9 |
Journal | Arteriosclerosis, thrombosis, and vascular biology |
Volume | 15 |
Issue number | 10 |
DOIs | |
State | Published - Oct 1995 |
Externally published | Yes |
Keywords
- apoE
- gene- gene interaction
- hyperlipoproteinemia
- lipoprotein lipase
- missense mutations
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine